Skip to content

Trial · Interventional

CompletedNot applicableResults postedRegistry data

Comparison of Pre-Induction Cervical Ripening

This trial does not test a peptide that PepBank tracks.

  • Names Oxytocin, does not test it. It appears in the summary.

Overview

Status
Completed
Phase
Not applicable
Enrollment
102 participants (actual)
Sponsor
University of South Carolina · Other
Design
Randomized · Open label (no masking)
Countries
1 country

United States

Start
Jul 2010
Primary completion
Feb 2013
Completion
May 2013
First posted
8 Jul 2011 (estimated)
Last update posted
30 May 2014 (estimated)
Conditions
Failed Labour

Timeline

1 trial · 1 completed · 1 with posted results

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
20102011201220132014
  1. N/A

    Comparison of Pre-Induction Cervical Ripening

    NCT01390233

    Jul 2010 to May 2013

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

This study is designed to assess the effectiveness of a combination method of induction of labor using a urinary balloon catheter and prostaglandin gel. The vaginal delivery rate for medical induction of labor is lower than the vaginal delivery rate for spontaneous labor. As a consequence, the frequency of cesarean section for failed induction in the United States is rising. This has led to a renewed effort to examine the effectiveness of the varied methods of induction. The study is a randomized, unblinded trial of urinary balloon catheter and prostaglandin gel for induction of labor in term pregnant patients. Pregnant women presenting to the Palmetto Health Richland for a scheduled induction of labor will be offered enrollment in the trial. Patients who enroll in the study will be randomized into one of 3 study arms: urinary balloon catheter only, prostaglandin gel only and combination urinary balloon catheter and prostaglandin gel. Randomization will be per sealed envelope from the locked nurse medication storage area (Pyxis) located in Labor and Delivery at Palmetto Health Richland. The investigator will be given the next sequentially numbered study randomization envelope by the patient's nurse. The randomization assignment will be unblinded to the patient and her physicians. If the patient is not in active labor 6 hours after initiation of the intervention, a standardized protocol of oxytocin will commence. Labor management will be at the discretion of the physician.

Interventions

  • Prepidil GelDrug
  • Urinary Balloon CatheterDevice
  • Combined Urinary Catheter & Prepidil GelOther

Arms3

  • Active comparator

    Urinary Balloon Catheter Only

    A urinary balloon catheter will be placed through the cervix into the lower uterine segment and the bulb inflated with 40ml of saline. The catheter will be taped to the patient's thigh and placed under traction using a liter bag of saline. The catheter will be deflated and removed after 6 hours. If spontaneously expelled from the uterus, time of expulsion will be noted. Six hours after insertion of catheter, a digital exam will be performed and Bishop score recorded. If no active labor at time of catheter removal or expulsion, standardized protocol of oxytocin will commence. Labor management will be at the discretion of the physician.

  • Active comparator

    Prepadil Only

    Prepidil Only : Prepidil gel will be inserted into the vaginal fornix according to manufacturer's direction. No oxytocin or other intervention will commence until 6 hours after insertion of gel. Six hours after insertion of gel, digital exam will be performed and Bishop score recorded. If no active labor 6 hours after the administration of gel, standardized protocol of oxytocin will commence. Labor management will be at the discretion of the physician.

  • Experimental

    Combined Urinary Catheter & Prepidil Gel

    A urinary balloon catheter will be placed through the cervix into the lower uterine segment and the bulb inflated with 40ml of saline. The catheter will be taped to the patient's thigh and placed under traction using a liter bag of saline. Prepidil gel will be inserted through the catheter into the lower uterine segment, in a dose equivalent to manufacturer's recommendation. No oxytocin or other intervention will commence until 6 hours after insertion of the catheter and administration of prepidil gel (even if catheter is spontaneously expelled). After 6 hours, digital exam will be performed and Bishop score recorded. If no active labor, standardized protocol of oxytocin will commence.

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Vaginal Delivery

    Time frame · Gestational age 26-42 weeks

    Registry description

    The primary outcome of this study is vaginal delivery of a liveborn singleton pregnancy. The outcome is considered a vaginal delivery if accomplished by spontaneous vaginal delivery, operative forceps or vacuum forceps. The alternate outcome is delivery by cesarean section.

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

Primary outcome results

Primary outcomeNumber· Gestational age 26-42 weeks

Vaginal Delivery

GroupValue (participants)
Urinary Balloon Catheter Only20
Prepadil Only21
Combined Urinary Catheter & Prepadil Gel20

Adverse events, as posted

Adverse events as posted: participants affected out of participants at risk, by group
GroupDeathsSerious eventsOther events
Urinary Balloon Catheter OnlyA urinary balloon catheter will be placed through the cervix into the lower uterine segment and the bulb inflated with 40ml of saline. The catheter will be taped to the patient's thigh and placed under traction using a liter bag of saline. The catheter will be deflated and removed after 6 hours. If spontaneously expelled from the uterus, time of expulsion will be noted. Six hours after insertion of catheter, a digital exam will be performed and Bishop score recorded. If no active labor at time of catheter removal or expulsion, standardized protocol of oxytocin will commence. Labor management will be at the discretion of the physician. Urinary Balloon Catheter: Pre-induction cervical ripening using a urinary balloon catheter device.–0 / 350 / 35
Prepadil OnlyPrepidil gel will be inserted into the vaginal fornix according to manufacturer's direction. No oxytocin or other intervention will commence until 6 hours after insertion of gel. Six hours after insertion of gel, digital exam will be performed and Bishop score recorded. If no active labor 6 hours after the administration of gel, standardized protocol of oxytocin will commence. Labor management will be at the discretion of the physician. Dinoprostone Gel: Pre-induction cervical ripening using dinoprostone gel in the vagina.–0 / 310 / 31
Combined Urinary Catheter & Prepadil GelA urinary balloon catheter will be placed through the cervix into the lower uterine segment and the bulb inflated with 40ml of saline. The catheter will be taped to the patient's thigh and placed under traction using a liter bag of saline. Prepidil gel will be inserted through the catheter into the lower uterine segment, in a dose equivalent to manufacturer's recommendation. No oxytocin or other intervention will commence until 6 hours after insertion of the catheter and administration of prepidil gel (even if catheter is spontaneously expelled). After 6 hours, digital exam will be performed and Bishop score recorded. If no active labor, standardized protocol of oxytocin will commence. Urinary Balloon Catheter Device and Dinoprostone Gel: Pre-induction cervical ripening using dinoprostone gel injected through a urinary balloon catheter placed in the lower uterine segment.–1 / 360 / 36

Each cell reads participants affected / participants at risk, as the registry posted them.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies12

Studies that cite this trial.

More studies

12 studies on this page

Indexing hint: Systematic review · 2023

Mechanical methods for induction of labour.

de Vaan et al. 2023The Cochrane database of systematic reviewscited by 38

PMID 36996264PMC10061553DOI 10.1002/14651858.cd001233.pub4PUB-36996264

Free to read · publisher termsCC BY-NC
Read at source

Indexing hint: Meta-analysis (pooled) · 2009

Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.

Kelly et al. 2009The Cochrane database of systematic reviewscited by 50

PMID 19821301DOI 10.1002/14651858.cd003101.pub2PUB-19821301

Full text at the publisher
Publisher page

PubMed tag: none · 2007

Cervical ripening with the Foley catheter.

Cromi et al. 2007International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetricscited by 10

PMID 17316649DOI 10.1016/j.ijgo.2006.10.014PUB-17316649

Full text at the publisher
Publisher page

PubMed tag: none · 2006

ACOG Committee Opinion No. 342: induction of labor for vaginal birth after cesarean delivery.

Obstetrics and gynecologycited by 33

PMID 16880321DOI 10.1097/00006250-200608000-00045PUB-16880321

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 2005

Randomised trial of intravaginal misoprostol and intracervical Foley catheter for cervical ripening and induction of labour.

Owolabi et al. 2005Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecologycited by 27

PMID 16234141DOI 10.1080/01443610500231450PUB-16234141

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 2004

Comparison of prostaglandin E2 tablets or Foley catheter for labour induction in grand multiparas.

Al-Taani et al. 2004Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassitcited by 13

PMID 16335645DOI 10.26719/2004.10.4-5.547PUB-16335645

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 2001

Preinduction cervical ripening techniques compared.

Greybush et al. 2001The Journal of reproductive medicinecited by 17

PMID 11209625PUB-11209625

Full text at the publisher

Indexing hint: Randomized controlled trial · 2001

Balloon cervical ripening with extra-amniotic infusion of saline or prostaglandin E2: a double-blind, randomized controlled study.

Sherman et al. 2001Obstetrics and gynecologycited by 14

PMID 11239640DOI 10.1016/s0029-7844(00)01168-6PUB-11239640

Full text at the publisher
Publisher page

Indexing hint: Clinical trial · 2001

Extra-amniotic Foley catheter and prostaglandin E(2) gel for cervical ripening at term gestation.

Ghezzi et al. 2001European journal of obstetrics, gynecology, and reproductive biologycited by 10

PMID 11451546DOI 10.1016/s0301-2115(00)00544-3PUB-11451546

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 1998

Extraamniotic saline infusion is promising in preparing the cervix for induction of labor.

Hemlin et al. 1998Acta obstetricia et gynecologica Scandinavicacited by 16

PMID 9492717DOI 10.1080/00016349808565810PUB-09492717

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 1995

Induction of labour at term in primigravidae with low Bishop's score: a comparison of three methods.

Orhue et al. 1995European journal of obstetrics, gynecology, and reproductive biologycited by 24

PMID 7774736DOI 10.1016/0028-2243(94)01963-0PUB-07774736

Full text at the publisher
Publisher page

Indexing hint: Randomized controlled trial · 1986

Preparation for induction of labour of the unfavourable cervix with Foley catheter compared with vaginal prostaglandin.

Thomas et al. 1986The Australian & New Zealand journal of obstetrics & gynaecologycited by 21

PMID 3524549DOI 10.1111/j.1479-828x.1986.tb01524.xPUB-03524549

Full text at the publisher
Publisher page

Eligibility

Who could join, as posted.

Sex
Female
Age
from 18 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: 1. Single, live fetus 2. Cephalic (head-first) presentation 3. Reassuring fetal health assessment 4. Gestational age between 26 and 42 weeks 5. Maternal age 18 and above 6. Bishop score less than 5 Exclusion Criteria: 1. Multiple Gestation (twins, triplets, quadruplets) 2. Fetal demise 3. Fetal malpresentation 4. Estimated fetal weight less than 500 grams or more than 4000 grams 5. Placenta previa 6. Non-reassuring fetal health assessment 7. Maternal asthma 8. Latex allergy 9. Spontaneous labor 10. Other contraindication to vaginal delivery

PepBank is a research reference. Talk to a doctor before you use any peptide.